vimarsana.com

Page 2 - சிரோனா உயிர் வேதியியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/R E P E A T -- Sirona Biochem CEO Quarterly Update Q2 2021/

/R E P E A T -- Sirona Biochem CEO Quarterly Update Q2 2021/
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.

/R E P E A T -- Sirona Biochem Announces Launch of First Commercial Product Containing TFC-1067/

Sirona Biochem Corp . is pleased to announce the launch of the first commercial product containing the Company’s proprietary ingredient, TFC-1067. TFC-1067 will debut as the active ingredient in New Rodan + Fields REVERSE Targeted Dark Spot Corrector. It will precisely target stubborn discoloration for a brighter, even-looking skin tone. Rodan + Fields licensed TFC-1067 from Sirona in 2019. In Rodan + Fields … Sirona Biochem Corp . (TSXV: SBM) (FSE: ZSB) (US-OTC: SRBCF) is pleased to announce the launch of the first commercial product containing the Company’s proprietary ingredient, TFC-1067. TFC-1067 will debut as the active ingredient in New Rodan + Fields REVERSE Targeted Dark Spot Corrector. It will precisely target stubborn discoloration for a brighter, even-looking skin tone.

Sirona Biochem CEO Quarterly Update Q1 2021

Sirona Biochem Corp .  is pleased to provide the following update to shareholders. We continue to make substantial progress with core deliverables. TFC-1067 Rodan + Fields is completing the final stages in preparation to launch one of their newest skin care products incorporating TFC-1067. The dates are tightly guarded at this time and shareholders will be updated as soon as we are able to do so. We can report that .

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.